Hydrochlorothiazide does not increase furosemide's effects in end-stage renal disease.

Huh, Wooseong; Oh, Ha-Young; Han, Jin Suk; Jang, In-Jin; Yim, Dong-Seok

Huh, Wooseong; Oh, Ha-Young; Han, Jin Suk; Jang, In-Jin; Yim, Dong-Seok.

Afiliação

Huh W; Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Oh HY; Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Han JS; Department of Internal Medicine, College of Medicine, Seoul National University College of Medicine and Hospital, Seoul 03080, Korea.
Jang IJ; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Korea.
Yim DS; PIPET (Pharmacometrics Institute for Practical Education and Training), College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.

Transl Clin Pharmacol ; 25(1): 28-33, 2017 Mar.

Article em En | MEDLINE | ID: mdl-32095456

Palavras-chave

ESRD; Furosemide; Thiazide

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Idioma: En Revista: Transl Clin Pharmacol Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google